⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Cell and Gene Therapy Market to Exceed US$105B by 2033, Driving Strategic Value Across Healthcare Portfolios | According to DataM Intelligence
prnewswire.com
EDIT
NTLA
RPTX
NVS
GILD
BMY
VRTX
CRL
OCGN
Magic Johnson Joins Visionary Entrepreneur Sean Callagy on "Unblinded" Podcast for Inspiring Conversation on Excellence, Integrity and Leadership
accessnewswire.com
TMUS
DIS
BMY
CRM
MA
Global Healthy Living Foundation Expands Access to Education and Clinical Trial Information for Spanish-Speaking Lupus Communities
businesswire.com
BMY
La Fundación Global para una Vida Saludable Amplía El Acceso A Educación e Información Sobre Ensayos Clínicos Para Comunidades Hispanohablantes Con Lupus
businesswire.com
BMY
Incyte Japan gibt die Zulassung von Minjuvi ® (Tafasitamab) in Kombination mit Rituximab und Lenalidomid zur Behandlung von rezidiviertem oder refraktärem follikulärem Lymphom bekannt
businesswire.com
INCY
BMY
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
businesswire.com
BMY
Mike Tyson on Discipline, Power and the Cost of Greatness; World Heavyweight Champion Sits Down With Visionary Entrepreneur Sean Callagy for Unforgettable Episode of "Unblinded" Podcast
accessnewswire.com
BMY
DIS
CRM
TMUS
MA
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
businesswire.com
BMY
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
globenewswire.com
BNTX
CVAC
BMY
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
PFE
SNY
TSEM
JNJ
LLY
MRK
BMY
ABBV
GILD
CRSP
NKTR
INCY